Skip Header

You are using a version of browser that may not display all the features of this website. Please consider upgrading your browser.
1 to 25 of 66  Show
  1. 1
    "Cloning and expression of the human and mouse UBP41."
    Gong L., Yeh E.T.H.
    Submitted (JUL-1998) to the EMBL/GenBank/DDBJ databases
    Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
    Category: Sequences.
    Tissue: Placenta.
    Source: UniProtKB/Swiss-Prot (reviewed).
  2. 2
    "Molecular cloning and characterization of USP2b in the human prostate cancer cell line LNCaP."
    Rossi S., Graner E., Weinstein L.J., Loda M.
    Submitted (OCT-2001) to the EMBL/GenBank/DDBJ databases
    Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4).
    Category: Sequences.
    Tissue: Prostate cancer.
    Source: UniProtKB/Swiss-Prot (reviewed).
  3. 3
    "Complete sequencing and characterization of 21,243 full-length human cDNAs."
    Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.
    Sugano S.
    Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 4).
    Category: Sequences.
    Tissue: Testis.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 12927 other entries.

  4. 4
    NHLBI resequencing and genotyping service (RS&G)
    Submitted (FEB-2007) to the EMBL/GenBank/DDBJ databases
    Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA].
    Category: Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).
  5. 5
    Category: Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 4309 other entries.

  6. 6
    Category: Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).
  7. 7
    "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."
    The MGC Project Team
    Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3).
    Category: Sequences.
    Tissue: Lymph and Testis.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 50450 other entries.

  8. 8
    "The deubiquitinating enzyme USP2a regulates the p53 pathway by targeting Mdm2."
    Stevenson L.F., Sparks A., Allende-Vega N., Xirodimas D.P., Lane D.P., Saville M.K.
    EMBO J. 26:976-986(2007) [PubMed] [Europe PMC] [Abstract]
    Cited for: FUNCTION, INTERACTION WITH MDM2, MUTAGENESIS OF HIS-549.
    Category: Function, Pathology & Biotech, Interaction.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 1 and mapped to 6 other entries.

  9. 9
    "Suppression of cancer cell growth by promoting cyclin D1 degradation."
    Shan J., Zhao W., Gu W.
    Mol. Cell 36:469-476(2009) [PubMed] [Europe PMC] [Abstract]
    Cited for: FUNCTION, INTERACTION WITH CCND1, MUTAGENESIS OF CYS-276.
    Category: Function, Pathology & Biotech, Interaction.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 1 and mapped to 4 other entries.

  10. 10
    "MdmX is a substrate for the deubiquitinating enzyme USP2a."
    Allende-Vega N., Sparks A., Lane D.P., Saville M.K.
    Oncogene 29:432-441(2010) [PubMed] [Europe PMC] [Abstract]
    Cited for: FUNCTION, INTERACTION WITH MDM2 AND MDM4, INDUCTION, MUTAGENESIS OF HIS-549.
    Category: Function, Pathology & Biotech, Expression, Interaction.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 2 and mapped to 14 other entries.

  11. 11
    "Expression of USP2-69 in mesangial cells in vivo and in vitro."
    Wang S., Wu H., Liu Y., Sun J., Zhao Z., Chen Q., Guo M., Ma D., Zhang Z.
    Pathol. Int. 60:184-192(2010) [PubMed] [Europe PMC] [Abstract]
    Cited for: TISSUE SPECIFICITY.
    Category: Expression.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 1 other entry.

  12. 12
    "Deubiquitylating enzyme USP2 counteracts Nedd4-2-mediated downregulation of KCNQ1 potassium channels."
    Krzystanek K., Rasmussen H.B., Grunnet M., Staub O., Olesen S.P., Abriel H., Jespersen T.
    Heart Rhythm 9:440-448(2012) [PubMed] [Europe PMC] [Abstract]
    Cited for: INTERACTION WITH KCNQ1.
    Category: Interaction.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 2 other entries.

  13. 13
    "Covalent ubiquitin-usp2 complex."
    Structural genomics consortium (SGC)
    Submitted (FEB-2009) to the PDB data bank
    Cited for: X-RAY CRYSTALLOGRAPHY (2.20 ANGSTROMS) OF 251-605.
    Category: Structure.
    Source: UniProtKB/Swiss-Prot (reviewed).
  14. 14
    Cited for: X-RAY CRYSTALLOGRAPHY (1.85 ANGSTROMS) OF 258-605 IN COMPLEX WITH UBIQUITIN AND ZINC-BINDING, ACTIVITY REGULATION.
    Category: Function, Interaction, Structure.
    Source: UniProtKB/Swiss-Prot (reviewed).
  15. 15
    "UBP41 is a proapoptotic ubiquitin-specific protease."
    Gewies A., Grimm S.
    Cancer Res. 63:682-688(2003) [PubMed] [Europe PMC] [Abstract]
    Category: Function, Pathology & Biotech.
    Annotation: Overexpression of Ubp41 is sufficient to elicit all features of apoptosis in human cells.
    Source: GeneRIF:9099.

    This publication is mapped to 1 other entry.

  16. 16
    "Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes."
    Micheau O., Tschopp J.
    Cell 114:181-190(2003) [PubMed] [Europe PMC] [Abstract]
    Category: Function.
    Annotation: Pathway.
    Source: Reactome:R-HSA-5212661.

    This publication is mapped to 20 other entries.

  17. 17
    "The isopeptidase USP2a regulates the stability of fatty acid synthase in prostate cancer."
    Graner E., Tang D., Rossi S., Baron A., Migita T., Weinstein L.J., Lechpammer M., Huesken D., Zimmermann J., Signoretti S., Loda M.
    Cancer Cell 5:253-261(2004) [PubMed] [Europe PMC] [Abstract]
    Category: Function.
    Annotation: the isopeptidase USP2a plays a critical role in prostate cancer cell survival.
    Source: GeneRIF:9099.

    This publication is mapped to 1 other entry.

  18. 18
    Category: Interaction.
    Source: IntAct:O75604.

    This publication is mapped to 1493 other entries.

  19. 19
    "TAK1 is recruited to the tumor necrosis factor-alpha (TNF-alpha) receptor 1 complex in a receptor-interacting protein (RIP)-dependent manner and cooperates with MEKK3 leading to NF-kappaB activation."
    Blonska M., Shambharkar P.B., Kobayashi M., Zhang D., Sakurai H., Su B., Lin X.
    J. Biol. Chem. 280:43056-43063(2005) [PubMed] [Europe PMC] [Abstract]
    Category: Function.
    Annotation: Pathway.
    Source: Reactome:R-HSA-5212661.

    This publication is mapped to 40 other entries.

  20. 20
    "Activation of IKK by TNFalpha requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO."
    Ea C.K., Deng L., Xia Z.P., Pineda G., Chen Z.J.
    Mol. Cell 22:245-257(2006) [PubMed] [Europe PMC] [Abstract]
    Category: Function.
    Annotation: Pathway.
    Source: Reactome:R-HSA-5212661.

    This publication is mapped to 37 other entries.

  21. 21
    "Evidence that TNF-TNFR1-TRADD-TRAF2-RIP-TAK1-IKK pathway mediates constitutive NF-kappaB activation and proliferation in human head and neck squamous cell carcinoma."
    Jackson-Bernitsas D.G., Ichikawa H., Takada Y., Myers J.N., Lin X.L., Darnay B.G., Chaturvedi M.M., Aggarwal B.B.
    Oncogene 26:1385-1397(2007) [PubMed] [Europe PMC] [Abstract]
    Category: Function.
    Annotation: Pathway.
    Source: Reactome:R-HSA-5212661.

    This publication is mapped to 17 other entries.

  22. 22
    "UCP2 A55V variant is associated with obesity and related phenotypes in an aboriginal community in Taiwan."
    Wang T.N., Huang M.C., Lin H.L., Hsiang C.H., Ko A.M., Chang W.T., Ko Y.C.
    Int J Obes (Lond) 31:1746-1752(2007) [PubMed] [Europe PMC] [Abstract]
    Category: Pathology & Biotech.
    Annotation: Associated with METABOLIC: insulin obesity.
    Source: GAD:155019.

    This publication is mapped to 9 other entries.

  23. 23
    "[Differential expression of USP2, USP14 and UBE4A between ovarian serous cystadenocarcinoma and adjacent normal tissues]."
    Yang Y., Hou J.Q., Qu L.Y., Wang G.Q., Ju H.W., Zhao Z.W., Yu Z.H., Yang H.J.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 23:504-506(2007) [PubMed] [Europe PMC] [Abstract]
    Category: Expression.
    Annotation: USP2 were over-expressed in ovarian serous cystadenocarcinoma tissues suggesting that the activity of ubiquitin-proteasome system is obviously enhanced in ovarian cancer.
    Source: GeneRIF:9099.

    This publication is mapped to 10 other entries.

  24. 24
    "NF-kappaB suppression by the deubiquitinating enzyme Cezanne: a novel negative feedback loop in pro-inflammatory signaling."
    Enesa K., Zakkar M., Chaudhury H., Luong le A., Rawlinson L., Mason J.C., Haskard D.O., Dean J.L., Evans P.C.
    J. Biol. Chem. 283:7036-7045(2008) [PubMed] [Europe PMC] [Abstract]
    Category: Function.
    Annotation: Pathway.
    Source: Reactome:R-HSA-5212661.

    This publication is mapped to 22 other entries.

  25. 25
    "Molecular discrimination of structurally equivalent Lys 63-linked and linear polyubiquitin chains."
    Komander D., Reyes-Turcu F., Licchesi J.D., Odenwaelder P., Wilkinson K.D., Barford D.
    EMBO Rep. 10:466-473(2009) [PubMed] [Europe PMC] [Abstract]
    Category: Interaction.
    Source: IntAct:O75604.

    This publication is mapped to 11 other entries.

1 to 25 of 66  Show
UniProt is an ELIXIR core data resource
Main funding by: National Institutes of Health

We'd like to inform you that we have updated our Privacy Notice to comply with Europe’s new General Data Protection Regulation (GDPR) that applies since 25 May 2018.

Do not show this banner again